REYOBIQ
Live / Applied — First extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Not registered yet, but its 09 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99128434
- Mark type
- Design + words
- Filed
- 09 Apr 2025
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Paolo A. Strino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and radiotherapeutic preparations, namely, therapeutic anti-cancer drugs; biopharmaceuticals for the treatment of cancers; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancers
Owner
- Plus Therapeutics, Inc., Houston, TX, US
- Plus Therapeutics, Inc., Houston, TX, US
Prosecution history
- 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 1 GRANTED
- 09 Mar 2026 — SOU EXTENSION 1 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Sept 2025 — ASSIGNED TO EXAMINER
- 20 Aug 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 20 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED